Marie Thibault
Stock Analyst at BTIG
(0.06)
# 4,723
Out of 5,005 analysts
753
Total ratings
39%
Success rate
-8.9%
Average return
Main Sectors:
Stocks Rated by Marie Thibault
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PLSE Pulse Biosciences | Initiated Coverage: Buy | $70 | $52.32 | +33.79% | 1 | Sep 23, 2026 | |
| HYPR Hyperfine | Reiterated: Buy | $2 | $0.8359 | +139.26% | 8 | Sep 22, 2026 | |
| CBLL CeriBell | Reiterated: Buy | $30 | $24.51 | +22.40% | 14 | Sep 21, 2026 | |
| KMTS Kestra Medical Technologies | Reiterated: Buy | $32 | $28.13 | +13.76% | 12 | Sep 15, 2026 | |
| EW Edwards Lifesciences | Reiterated: Buy | $110 | $86.83 | +26.68% | 45 | Sep 10, 2026 | |
| OBIO Orchestra BioMed Holdings | Upgraded: Buy | $10 | $5.89 | +69.78% | 9 | Sep 10, 2026 | |
| BSX Boston Scientific | Rated: Buy | $65 → $56 | $44.11 | +26.96% | 79 | Sep 9, 2026 | |
| MMED MiniMed Group | Reiterated: Buy | $25 → $28 | $20.49 | +36.65% | 5 | Sep 1, 2026 | |
| ATRC AtriCure | Reiterated: Buy | $45 → $55 | $58.41 | -5.84% | 54 | Aug 24, 2026 | |
| ABT Abbott Laboratories | Reiterated: Buy | $134 | $100.98 | +32.70% | 54 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $185 | $112.60 | +64.30% | 62 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $9.84 | - | 40 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $133.11 | - | 51 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 → $90 | $86.68 | +3.83% | 56 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $17 | $15.81 | +7.53% | 31 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.59 | - | 16 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.2998 | - | 39 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $84 | $105.79 | -20.60% | 13 | Jun 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $5.93 | - | 28 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $2.96 | +406.76% | 18 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $62 | $65.34 | n/a | 55 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $150 | $338.40 | n/a | 1 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $319.18 | n/a | 1 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 37 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $89 | $89.50 | n/a | 1 | Feb 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.56 | n/a | 23 | Dec 16, 2022 |
Pulse Biosciences
Sep 23, 2026
Initiated Coverage: Buy
Price Target: $70
Current: $52.32
Upside: +33.79%
Hyperfine
Sep 22, 2026
Reiterated: Buy
Price Target: $2
Current: $0.8359
Upside: +139.26%
CeriBell
Sep 21, 2026
Reiterated: Buy
Price Target: $30
Current: $24.51
Upside: +22.40%
Kestra Medical Technologies
Sep 15, 2026
Reiterated: Buy
Price Target: $32
Current: $28.13
Upside: +13.76%
Edwards Lifesciences
Sep 10, 2026
Reiterated: Buy
Price Target: $110
Current: $86.83
Upside: +26.68%
Orchestra BioMed Holdings
Sep 10, 2026
Upgraded: Buy
Price Target: $10
Current: $5.89
Upside: +69.78%
Boston Scientific
Sep 9, 2026
Rated: Buy
Price Target: $65 → $56
Current: $44.11
Upside: +26.96%
MiniMed Group
Sep 1, 2026
Reiterated: Buy
Price Target: $25 → $28
Current: $20.49
Upside: +36.65%
AtriCure
Aug 24, 2026
Reiterated: Buy
Price Target: $45 → $55
Current: $58.41
Upside: -5.84%
Abbott Laboratories
Aug 20, 2026
Reiterated: Buy
Price Target: $134
Current: $100.98
Upside: +32.70%
Aug 7, 2026
Reiterated: Buy
Price Target: $185
Current: $112.60
Upside: +64.30%
Aug 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $9.84
Upside: -
Aug 6, 2026
Downgraded: Hold
Price Target: n/a
Current: $133.11
Upside: -
Jul 31, 2026
Reiterated: Buy
Price Target: $80 → $90
Current: $86.68
Upside: +3.83%
Jul 13, 2026
Reiterated: Buy
Price Target: $16 → $17
Current: $15.81
Upside: +7.53%
Jul 10, 2026
Reiterated: Hold
Price Target: n/a
Current: $2.59
Upside: -
Jul 7, 2026
Rated: Hold
Price Target: n/a
Current: $0.2998
Upside: -
Jun 26, 2026
Reiterated: Buy
Price Target: $84
Current: $105.79
Upside: -20.60%
Jun 15, 2026
Reiterated: Hold
Price Target: n/a
Current: $5.93
Upside: -
Feb 18, 2026
Reiterated: Buy
Price Target: $15
Current: $2.96
Upside: +406.76%
Apr 10, 2025
Reiterated: Buy
Price Target: $62
Current: $65.34
Upside: n/a
Oct 27, 2023
Reiterated: Buy
Price Target: $150
Current: $338.40
Upside: n/a
Jul 26, 2023
Rated: Buy
Price Target: n/a
Current: $319.18
Upside: n/a
Jul 17, 2023
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Feb 21, 2023
Rated: Hold
Price Target: $89
Current: $89.50
Upside: n/a
Dec 16, 2022
Rated: Hold
Price Target: n/a
Current: $2.56
Upside: n/a